Arrowstreet Capital’s Alpine Immune Sciences Inc ALPN Stock Holding History

Arrowstreet Capital’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-18,982	Closed	-$752K	–	1840
2024 Q1	$752K	Buy	+18,982	New	+$560K	﹤0.01%	1373

Arrowstreet Capital's ALPN Position: Q2 2024 in Review

Arrowstreet Capital sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 18,982 shares — an estimated $752K sold.

Arrowstreet Capital first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $752K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Arrowstreet Capital reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Arrowstreet Capital sold 18,982 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $752K.
Arrowstreet Capital first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
Arrowstreet Capital's Alpine Immune Sciences Inc position peaked at $752K in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Arrowstreet Capital's 13F filing for Q2 2024, filed 14 Aug 2024.